CHORUS INFLUENZA B IGA
Mexico·Clase I·III. DIAGNOSTIC AGENTS·GRIFOLS MÉXICO, S.A. DE C.V.·Registered October 21, 2019REACTIVO PARA LA DETERMINACIÓN CUALITATIVA DE ANTICUERPOS IGA ANTI INFLUENZA B
REAGENT FOR THE QUALITATIVE DETERMINATION OF IGA ANTIBODIES TO INFLUENZA B
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- REACTIVO PARA LA DETERMINACIÓN CUALITATIVA DE ANTICUERPOS IGA ANTI INFLUENZA B
- Trade Name (English)
- REAGENT FOR THE QUALITATIVE DETERMINATION OF IGA ANTIBODIES TO INFLUENZA B
- Analysis ID
- 2022R2019 SSA
- Registration Date
- October 21, 2019
- Name (Spanish)
- GRIFOLS MÉXICO, S.A. DE C.V.
- Name (English)
- GRIFOLS MÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for CHORUS INFLUENZA B IGA (CHORUS INFLUENZA B IGA) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 2022R2019 SSA and manufactured by GRIFOLS MÉXICO, S.A. DE C.V.. The device was registered on October 21, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.